Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

June 22, 2022

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

June 22, 2022

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

June 22, 2022

New GLP-1 receptor agonists identified at Shenzhen Salubris Pharmaceuticals

June 22, 2022

New cyclin-dependent kinase inhibitors divulged by Allorion Therapeutics

June 21, 2022

Peking University describes radiation-activated tetravalent platinum complex

June 21, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group patent vasopressin receptor antagonists

June 21, 2022

New phosphodiesterase PDE4B1 inhibitors discovered at Reistone Biopharma

June 21, 2022

Hangzhou Polymed Biopharmaceuticals identifies new G12C mutant KRAS inhibitors

June 21, 2022

RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates

June 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...